Exparel for Postoperative Pain Management in Shoulder Surgery

NCT02472314 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2023-12-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effect of liposomal Bupivacaine infiltration into the shoulder to continues nerve block with Bupivacaine on postoperative pain control and functional outcomes.

Conditions

  • Fracture of Shoulder and Upper Arm

Interventions

DRUG

1.3% Liposomal Bupivacaine

local tissue infiltration of Liposomal Bupivacaine during surgery

DRUG

0.125% Bupivacaine

Continues nerve block with Bupivacaine during surgery and postoperatively

Sponsors & Collaborators

  • Wayne State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02472314 on ClinicalTrials.gov